Elsevier Science, Inc.

SHERPA: Unknown

People

  1. Herr
    Herr
  2. Vickers
    Vickers
  3. Russo
    Russo
  4. Eastham
    Eastham
  5. Jarnagin
    Jarnagin
  6. Reuter
    Reuter
  7. D'Angelica
    D'Angelica
  8. Kingham
    Kingham
  9. Ladanyi
    Ladanyi
  10. Scher
    Scher

Groups

  1. Surgery (2049)
  2. Department of Medicine (1334)
  3. Urology (1158)
  4. Solid Tumor Oncology Division (829)
  5. Population Sciences Research Program (816)
  6. Survivorship Research (716)
  7. Epidemiology and Biostatistics (685)
  8. Sloan Kettering Institute Faculty (612)
  9. Department of Pathology and Laboratory Medicine (586)
  10. GSK Faculty (582)
Search Within
Formats
  1. Journal Article (3901)
  2. Meeting Abstract (1049)
  3. Editorial (165)
  4. Review (132)
  5. Correspondence (113)
  6. Guidelines (79)
  7. Research Letter (29)
  8. Conference Paper (27)
  9. Book Section (5)
  10. Miscellaneous (3)
Groups
  1. Surgery (2049)
  2. Department of Medicine (1334)
  3. Urology (1158)
  4. Solid Tumor Oncology Division (829)
  5. Population Sciences Research Program (816)
  6. Survivorship Research (716)

More Groups

People
  1. Harry Herr (270)
  2. Andrew Vickers (223)
  3. Paul Russo (185)
  4. Peter Scardino (173)
  5. James Eastham (161)
  6. William Jarnagin (157)

More People

Years
  1. 2025 (96)
  2. 2024 (256)
  3. 2023 (234)
  4. 2022 (264)
  5. 2021 (233)
  6. 2020 (264)

More Years

Publications
  1. Journal of Urology (762)
  2. European Urology (570)
  3. Lancet Oncology (394)
  4. Urology (388)
  5. Journal of the American College of Surgeons (346)
  6. Journal of Molecular Diagnostics (272)

More Publications

Results (5503)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Recommendations for tumor mutational burden assay validation and reporting: A joint consensus recommendation of the Association for Molecular Pathology, College of American Pathologists, and Society for Immunotherapy of Cancer
    Review

    Furtado, L. V.; Bifulco, C.; Dolderer, D.; Hsiao, S. J.; Kipp, B. R.; Lindeman, N. I.; Ritterhouse, L. L.; Temple-Smolkin, R. L.; Zehir, A.; Nowak, J. A.
    Journal of Molecular Diagnostics (2024)

    Fulltext@MSK | Save
  • Re: Thibault et al.: Drug-induced uveitis related to checkpoint inhibitors and MAP-kinase inhibitors (Ophthalmology. 2024;131:249–251)
    Correspondence

    Francis, J. H.; Canestraro, J.; Abramson, D. H.
    Ophthalmology (2024)

    Fulltext@MSK | Save
  • Histopathologic changes after yttrium-90 radioembolization of colorectal liver metastases: A pilot feasibility study
    Journal Article

    Kitsel, Y.; Vakiani, E.; Kirov, A.; Zirakchian Zadeh, M.; Kunin, H.; Petre, E. N.; Crane, C. H.; Romesser, P.; Sotirchos, V. S.; Sofocleous, C. T.
    Journal of Vascular and Interventional Radiology (2024)

    Fulltext@MSK | Save
  • Reply to Peter Ka-Fung Chiu, Xiaobo Wu, Giorgio Gandaglia, European Association of Urology Young Academic Urologists Prostate Cancer Working Party. Beyond Statistical Significance: Unveiling the Advantages of Transperineal Versus Transrectal Prostate Biopsies. Eur Urol. In press
    Correspondence

    Hu, J. C.; Vickers, A. J.; Schaeffer, E. M.
    European Urology (2024)

    Fulltext@MSK | Save
  • Baseline serum prostate-specific antigen value predicts the risk of subsequent prostate cancer death—Results from the Norwegian Prostate Cancer Consortium
    Journal Article

    Bjerner, J.; Bratt, O.; Aas, K.; Albertsen, P. C.; Fosså, S. D.; Kvåle, R.; Lilja, H.; Müller, C.; Müller, S.; Stensvold, A.; more...
    European Urology (2024)

    Fulltext@MSK | Save
  • Reply to Ilias Giannakodimos’ letter to the editor re: Jim C. Hu, Melissa Assel, Mohamad E. Allaf, et al. Transperineal versus transrectal magnetic resonance imaging-targeted and systematic prostate biopsy to prevent infectious complications: The PREVENT randomized trial. Eur Urol. 2024;86:61–68
    Correspondence

    Hu, J. C.; Schaeffer, E. M.; Vickers, A. J.
    European Urology (2024)

    Fulltext@MSK | Save
  • Reply to Geoffrey H. Rosen, Nicholas H. Chakiryan, and Katie S. Murray's Letter to the Editor re: Jim C. Hu, Melissa Assel, Mohamad E. Allaf, et al. Transperineal versus transrectal magnetic resonance imaging–targeted and systematic prostate biopsy to prevent infectious complications: The PREVENT randomized trial. Eur Urol. 2024;86:61–68
    Correspondence

    Hu, J. C.; Vickers, A. J.; Schaeffer, E. M.
    European Urology (2024)

    Fulltext@MSK | Save
  • Transperineal versus transrectal magnetic resonance imaging–targeted and systematic prostate biopsy to prevent infectious complications: The PREVENT randomized trial
    Journal Article

    Hu, J. C.; Assel, M.; Allaf, M. E.; Ehdaie, B.; Vickers, A. J.; Cohen, A. J.; Ristau, B. T.; Green, D. A.; Han, M.; Rezaee, M. E.; more...
    European Urology (2024)

    Fulltext@MSK | Save
  • Amount of Gleason pattern 3 is not predictive of risk in grade group 2–4 prostate cancer
    Editorial

    Vickers, A. J.; Assel, M.; Cooperberg, M. R.; Fine, S. W.; Eggener, S.
    European Urology (2024)

    Fulltext@MSK | Save
  • Characterization of responses to lenvatinib plus pembrolizumab in patients with advanced renal cell carcinoma at the final prespecified survival analysis of the phase 3 CLEAR study
    Journal Article

    Motzer, R. J.; Choueiri, T. K.; Hutson, T.; Young Rha, S.; Puente, J.; Lalani, A. K. A.; Winquist, E.; Eto, M.; Basappa, N. S.; Tannir, N. M.; more...
    European Urology (2024)

    Fulltext@MSK | Save